Cancer health disparities persist in both cancer incidence and outcome. Multiple factors contribute, including socioeconomic, socio-environmental, behavioral, and biological. Additionally, increasing amounts of evidence underscore the contribution of comorbidities, chronic social stress, and even the microbiome may contribute to health disparities in cancer risk and survival. In this lecture we will examine disparities and associated factors in the most common cancer types (breast, prostate, lung and colon). Cancer treatment outcomes, enrollment in clinical trials, and quality of life among cancer survivors will also be discussed thru the lens of health equity. Finally, we will focus on the role that advanced practice providers can have in addressing cancer health disparities regardless of specialty. This session is best suited for all patient facing practitioners and those who participate in clinical research. Objectives include:
- Develop increased awareness of the disparities that exist regarding the diagnosis, treatment, and outcome of common cancer types.
- Explain how the lack of participation in clinical trials has created barriers to effective treatment for diverse/minority populations.
- Appreciate that racial and ethnic minority cancer survivors experience a disproportionate burden of the adverse effects of cancer and cancer treatment.
- Devise at least one actionable task they can take in their own practice to address the structural, environmental, or institutional factors that contribute to cancer health disparities.